Monday's Trending Stocks: CBS, Medivation, HPE, Boeing, Sagent Pharmaceuticals
The benchmark S&P 500 index has jumped six points on Monday, setting a new all-time high as last week’s strong jobs report continues to buoy market sentiment.
Sagent Pharmaceuticals Inc. (SGNT)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Stonepine Capital Timothy P. Lynch | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | Healthcare Value Capital Joe Riccardo | 0 | $0 | 0% | |
| 4. | Vivo Capital Albert Cha And Frank Kung | 0 | $0 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.69 | 2,000 | $31,380.00 | 20,615 | 2012-05-17 | Filing | |
| $20.18 | 1,000 | $20,180.00 | 3,000 | 2011-11-23 | Filing | |
| $19.75 | 1,000 | $19,750.00 | 2,000 | 2011-08-16 | Filing | |
| $19.95 | 1,000 | $19,950.00 | 1,000 | 2011-08-15 | Filing | |
| $16.00 | 20,000 | $320,000.00 | 26,379 | 2011-04-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.55 | 17 | $230.35 | 25,320 | 2016-04-21 | Filing | |
| $13.55 | 2,299 | $31,151.45 | 3,456,332 | 2016-04-21 | Filing | |
| $13.55 | 17 | $230.35 | 25,320 | 2016-04-21 | Filing | |
| $13.55 | 2,299 | $31,151.45 | 3,456,332 | 2016-04-21 | Filing | |
| $13.55 | 23 | $311.65 | 34,961 | 2016-04-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
What's the Deal With These Surging Stocks Amid Today's Gloomy Market?
U.S stocks did not spend too much time in green territory today, heading south soon after the opening bell.
A Look at Steve Cohen's Latest Portfolio Addition & Two Other Hedge Fund Bullish Moves
At Insider Monkey we follow around 730 hedge funds and other institutional investors and ahead of the New Year, several funds from our database have reported some interesting moves.
Hedge Funds Are Selling Sagent Pharmaceuticals Inc (SGNT)
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Do Hedge Funds and Insiders Love Akorn, Inc. (AKRX)?
To many of your peers, hedge funds are viewed as useless, old investment tools of an era lost to time.
Hedge Funds Are Betting On Momenta Pharmaceuticals, Inc. (MNTA)
Now, according to many market players, hedge funds are assumed to be bloated, outdated investment tools of a period lost to current times.
Hi-Tech Pharmacal Co. (HITK): Hedge Funds Aren't Crazy About It, Insider Sentiment Unchanged
To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.
This Metric Says You Are Smart to Buy Sagent Pharmaceuticals Inc (SGNT)
If you were to ask many of your fellow readers, hedge funds are seen as useless, old investment tools of a forgotten age.
Hedge Funds Are Crazy About Ligand Pharmaceuticals Inc. (LGND)
At the moment, there are dozens of methods investors can use to monitor the equity markets. Some of the most useful are hedge fund and insider trading interest.
Is Supernus Pharmaceuticals Inc (SUPN) Going to Burn These Hedge Funds?
To most shareholders, hedge funds are perceived as slow, outdated investment vehicles of yesteryear.